Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-23-127172
Filing Date
2023-04-28
Accepted
2023-04-28 16:35:22
Documents
19
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d487324d10ka.htm   iXBRL 10-K/A 890740
2 EX-31.1 d487324dex311.htm EX-31.1 2393
3 EX-31.2 d487324dex312.htm EX-31.2 2403
9 GRAPHIC g487324g34y29.jpg GRAPHIC 25123
10 GRAPHIC g487324g57o73.jpg GRAPHIC 22327
  Complete submission text file 0001193125-23-127172.txt   1343821

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA vtrs-20221231.xsd EX-101.SCH 5290
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vtrs-20221231_cal.xml EX-101.CAL 919
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vtrs-20221231_def.xml EX-101.DEF 3433
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtrs-20221231_lab.xml EX-101.LAB 23280
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtrs-20221231_pre.xml EX-101.PRE 19085
13 EXTRACTED XBRL INSTANCE DOCUMENT d487324d10ka_htm.xml XML 8787
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

EIN.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39695 | Film No.: 23867208
SIC: 2834 Pharmaceutical Preparations